Amneal Pharmaceuticals, Inc. (AMRX)

Amneal Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 4, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,603	1,861	301	715	675	646
Market Cap Growth	312.32%	517.28%	-57.87%	6.05%	4.38%	-62.48%
Enterprise Value	5,335	4,434	2,989	3,372	3,471	3,384
Last Close Price	8.41	6.07	1.99	4.79	4.57	4.82
PE Ratio	-	-12.65	-2.31	68.43	7.49	-1.76
PS Ratio	0.82	0.78	0.14	0.34	0.34	0.40
PB Ratio	-481.91	30.35	1.44	1.86	1.89	1.86
P/FCF Ratio	12.55	6.23	18.49	3.75	2.13	-14.21
P/OCF Ratio	10.31	5.38	4.63	2.96	1.78	379.09
EV/Sales Ratio	2.05	1.85	1.35	1.61	1.74	2.08
EV/EBITDA Ratio	9.26	8.85	6.79	7.49	9.11	14.66
EV/EBIT Ratio	15.19	16.34	14.94	15.57	23.83	-265.94
EV/FCF Ratio	25.72	14.84	183.29	17.67	10.94	-74.42
Debt / Equity Ratio	-670.06	44.87	13.62	7.52	8.41	7.99
Debt / EBITDA Ratio	4.56	5.26	6.15	6.15	7.36	10.78
Debt / FCF Ratio	13.14	9.21	174.49	15.13	9.46	-60.91
Asset Turnover	0.72	0.66	0.57	0.53	0.52	0.41
Inventory Turnover	2.90	2.75	2.79	2.67	3.07	2.77
Quick Ratio	0.76	0.87	1.09	1.39	1.49	1.43
Current Ratio	1.33	1.63	1.88	2.24	2.29	2.20
Return on Equity (ROE)	-148.99%	-36.06%	-85.96%	5.45%	19.50%	-97.10%
Return on Assets (ROA)	6.09%	4.66%	3.23%	3.41%	2.37%	-0.20%
Return on Capital (ROIC)	7.62%	5.78%	3.95%	4.09%	2.81%	-0.24%
Earnings Yield	-6.71%	-4.51%	-43.12%	1.48%	13.50%	-55.99%
FCF Yield	7.97%	16.06%	5.41%	26.68%	47.01%	-7.04%
Buyback Yield / Dilution	-66.75%	-16.69%	0.58%	-1.95%	-12.72%	-3.81%
Total Shareholder Return	-66.75%	-16.69%	0.58%	-1.95%	-12.72%	-3.81%

Source: S&P Capital IQ. Standard template. Financial Sources.